Trial Profile
Evaluation of morphological-based treatment regimen of aflibercept in patients with diabetic macular edema
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Mar 2020
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 28 Mar 2020 Status changed from not yet recruiting to completed.
- 03 Jan 2017 New trial record